...
首页> 外文期刊>Annals of Clinical Biochemistry >Comparison of biomarker strategies for rapid rule out of myocardial infarction in the emergency department using ACC/ESC diagnostic criteria
【24h】

Comparison of biomarker strategies for rapid rule out of myocardial infarction in the emergency department using ACC/ESC diagnostic criteria

机译:使用ACC / ESC诊断标准比较急诊科快速排除心肌梗死的生物标志物策略

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: Creatine kinase MB isoenzyme (CK-MB) mass and rate of change of CK-MB have been proposed as superior to cardiac troponin measurement for very early exclusion of acute myocardial infarction (AMI). All three markers were examined prospectively in patients presenting to the Emergency Department (ED) for rule out of AMI. nnMethods: Consecutive admissions to the ED with undifferentiated chest pain were initially assessed clinically and by electrocardiography. A total of 786 patients (490 male, median age 52.5 years) considered at low risk of AMI had blood drawn on admission. If the first sample was less than 12 h from onset of chest pain, a second sample was then drawn at least 2 h later and at least 6 h from onset of chest pain. CK-MB mass was measured on the first sample and CK-MB mass and cardiac troponin T (cTnT) were measured on the second sample. Measurement of cTnT was using an Elecsys 2010 with the third generation assay (Roche Diagnostics, Lewes, UK). Assay coefficient of variation (CV) was 5.8% and 5.7% at 0.47 and 11.5 µg/L, respectively, with measuring range 0.01-25.0 µg/L; analytical sensitivity of 0.01 µg/L and functional sensitivity of 0.03 µg/L. CK-MB (mass) was measured by electrochemiluminesence using an Elecsys 2010 (Roche Diagnostics). The assay CV was 4.0% at 5.89 µg/L and 4.1% at 60.5 µg/L, with a detection limit of 0.1 µg/L and an upper measuring limit of 500 µg/L. Myocardial infarction was diagnosed if either sample had a CK-MB of more than 5 µg/L, if there was a change in CK-MB (CK-MB) of more than 1.5 µg/L or if the cTnT was more than 0.05 µg/L. When AMI was excluded, patients proceeded to stress electrocardiography and reattended 72 h from presentation for follow up phlebotomy for cTnT measurement. A final diagnosis of AMI was made according to American College of Cardiology/ European Society of Cardiology criteria using a cut-off of 0.05 µg/L cTnT in any of the samples. Diagnostic efficiency was compared by receiver operator characteristic (ROC) curve analysis with comparison of area under the curve (AUC) for four strategies: admission CK-MB measurement; 6-h post-pain CK-MB measurement; CK-MB; and 6-h post-pain cTnT measurement. nnResults: On admission the AUC for CK-MB was 0.830 (95% confidence interval [CI] 0.757-0.904). At 6 h post pain the respective values were: CK-MB 0.939 (95% CI 0.889-0.988); -CK-MB 0.948 (95% CI 0.906-0.990); and cTnT 0.989 (95% CI 0.966-1.0). nnConclusion: cTnT at 6 h has high diagnostic sensitivity for AMI and is superior to CK-MB mass and CK-MB even using a low cut-off value.
机译:目的:提出了肌酸激酶MB同工酶(CK-MB)的质量和CK-MB的变化率优于心脏肌钙蛋白的测量,可在早期排除急性心肌梗塞(AMI)。前瞻性检查了急诊科(ED)排除AMI的患者的所有三个标记。 nn方法:最初通过临床和心电图评估连续入院的未分化胸痛的ED。总共786名被认为是AMI风险低的患者(男性490名,中位年龄52.5岁)在入院时抽血。如果第一个样品距胸痛发作少于12小时,则至少2小时后和距胸痛发作至少6小时再采集第二个样品。在第一个样品上测量CK-MB质量,在第二个样品上测量CK-MB质量和心肌肌钙蛋白T(cTnT)。 cTnT的测量使用Elecsys 2010和第三代测定法(英国罗威诊断公司,Roche Diagnostics)。在0.47和11.5 µg / L的测定变异系数(CV)分别为5.8%和5.7%,测量范围为0.01-25.0 µg / L。分析灵敏度为0.01 µg / L,功能灵敏度为0.03 µg / L。使用Elecsys 2010(Roche Diagnostics)通过电化学发光法测定CK-MB(质量)。测定CV在5.89 µg / L时为4.0%,在60.5 µg / L时为4.1%,检出限为0.1 µg / L,测量上限为500 µg / L。如果两个样品的CK-MB大于5 µg / L,CK-MB(CK-MB)的变化大于1.5 µg / L,或者cTnT大于0.05 µg,则诊断为心肌梗塞/升当排除AMI后,患者开始进行心电图检查,并在就诊后72小时重新就诊,进行随访放血术以进行cTnT测量。根据美国心脏病学会/欧洲心脏病学会的标准对AMI进行了最终诊断,在任何样品中均以0.05 µg / L cTnT的截止值为标准。通过四种方法将接受者操作员特征(ROC)曲线分析与曲线下面积(AUC)进行比较,比较诊断效率。疼痛后6小时CK-MB测量; CK-MB;和6小时疼痛后cTnT测量。结果:入院时CK-MB的AUC为0.830(95%置信区间[CI] 0.757-0.904)。疼痛后6小时,各自的值是:CK-MB 0.939(95%CI 0.889-0.988);和-CK-MB 0.948(95%CI 0.906-0.990); cTnT为0.989(95%CI为0.966-1.0)。 nn结论:6 h的cTnT对AMI具有很高的诊断敏感性,即使使用低截断值,也优于CK-MB质量和CK-MB。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号